Kalos Management, Inc. Gilead Sciences, Inc. Transaction History

Kalos Management, Inc.

$0
Q3 2023

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $11,544 - $13,002	-200 Reduced 5.75%	3,280 $203,000
Q1 2022 Jun 21, 2022	SELL	$57.92 - $72.58 $56,877 - $71,273	-982 Reduced 22.01%	3,480 $206,000
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $13,754 - $15,611	212 Added 4.99%	4,462 $298,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $4,196 - $4,527	62 Added 1.48%	4,250 $284,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $23,420 - $25,590	-369 Reduced 8.1%	4,188 $287,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $25,800 - $29,437	-430 Reduced 8.62%	4,557 $303,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $28,211 - $32,145	-498 Reduced 9.08%	4,987 $297,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $44,525 - $55,983	717 Added 15.04%	5,485 $343,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $7,234 - $8,400	-100 Reduced 2.05%	4,768 $364,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $24,864 - $31,847	397 Added 8.88%	4,868 $366,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $21,716 - $24,352	351 Added 8.52%	4,471 $302,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $40,206 - $45,042	-643 Reduced 13.5%	4,120 $267,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $43,588 - $56,880	-720 Reduced 13.13%	4,763 $301,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $32,860 - $36,382	-461 Reduced 7.76%	5,483 $404,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $385,646 - $449,841	5,944 New	5,944 $464,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $472,440 - $575,956	-6,486 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $217,292 - $255,070	3,054 Added 88.99%	6,486 $494,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $247,481 - $293,333	3,432	3,432 $278,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kalos Management, Inc. with notifications on news.

Account